Éloi Gagnon

824 total citations
26 papers, 235 citations indexed

About

Éloi Gagnon is a scholar working on Genetics, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Éloi Gagnon has authored 26 papers receiving a total of 235 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 11 papers in Epidemiology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Éloi Gagnon's work include Genetic Associations and Epidemiology (13 papers), Liver Disease Diagnosis and Treatment (10 papers) and Lipid metabolism and disorders (6 papers). Éloi Gagnon is often cited by papers focused on Genetic Associations and Epidemiology (13 papers), Liver Disease Diagnosis and Treatment (10 papers) and Lipid metabolism and disorders (6 papers). Éloi Gagnon collaborates with scholars based in Canada, United Kingdom and United States. Éloi Gagnon's co-authors include Benoît J. Arsenault, Patricia L. Mitchell, Sébastien Thériault, Hasanga D. Manikpurage, Patrick Mathieu, Erik Abner, Émilie Gobeil, Jérôme Bourgault, Tōnu Esko and Nooshin Ghodsian and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Éloi Gagnon

21 papers receiving 233 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Éloi Gagnon Canada 10 77 75 58 57 52 26 235
Daniela Siváková Slovakia 11 34 0.4× 57 0.8× 170 2.9× 53 0.9× 34 0.7× 51 342
K. Radha Mani India 4 36 0.5× 58 0.8× 104 1.8× 18 0.3× 55 1.1× 6 218
Elisabeth Widén Finland 2 36 0.5× 49 0.7× 162 2.8× 60 1.1× 31 0.6× 2 250
Xianghong Hu China 7 35 0.5× 86 1.1× 136 2.3× 17 0.3× 30 0.6× 7 263
Kuralay Atageldiyeva Kazakhstan 9 76 1.0× 52 0.7× 36 0.6× 15 0.3× 59 1.1× 25 291
Àngels Ulied Spain 10 42 0.5× 82 1.1× 105 1.8× 35 0.6× 28 0.5× 17 357
Temeka Zore United States 7 28 0.4× 60 0.8× 55 0.9× 32 0.6× 18 0.3× 12 316
Rasimcan Meral United States 12 53 0.7× 224 3.0× 106 1.8× 31 0.5× 48 0.9× 23 373
Sebastian Brokat Germany 6 34 0.4× 71 0.9× 28 0.5× 160 2.8× 16 0.3× 7 293
Dubravka Jurišić‐Eržen Croatia 8 92 1.2× 69 0.9× 110 1.9× 16 0.3× 107 2.1× 21 289

Countries citing papers authored by Éloi Gagnon

Since Specialization
Citations

This map shows the geographic impact of Éloi Gagnon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éloi Gagnon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éloi Gagnon more than expected).

Fields of papers citing papers by Éloi Gagnon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éloi Gagnon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éloi Gagnon. The network helps show where Éloi Gagnon may publish in the future.

Co-authorship network of co-authors of Éloi Gagnon

This figure shows the co-authorship network connecting the top 25 collaborators of Éloi Gagnon. A scholar is included among the top collaborators of Éloi Gagnon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Éloi Gagnon. Éloi Gagnon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gagnon, Éloi, Dipender Gill, Héléne T. Cronjé, et al.. (2025). Evaluating the Cardiometabolic Efficacy and Safety of Lipoprotein Lipase Pathway Targets in Combination With Approved Lipid-Lowering Targets: A Drug Target Mendelian Randomization Study. Circulation Genomic and Precision Medicine. 18(2). e004933–e004933. 1 indexed citations
2.
Gagnon, Éloi, Dipender Gill, Jérôme Bourgault, et al.. (2025). RNA interference versus antibody-based PCSK9 inhibition for the prevention of cardiovascular disease: a drug-target Mendelian randomization study. Cardiovascular Research. 121(7). 1066–1075.
3.
Gagnon, Éloi, Dipender Gill, Stephen Burgess, & Benoît J. Arsenault. (2025). Remnant cholesterol concentrations best explain the cardiovascular benefit of APOC3 genetic inhibition: A drug target Mendelian Randomization study. European Heart Journal Open. 5(2). oeaf018–oeaf018. 2 indexed citations
4.
Gobeil, Émilie, Jérôme Bourgault, Patricia L. Mitchell, et al.. (2024). Genetic inhibition of angiopoietin-like protein-3, lipids, and cardiometabolic risk. European Heart Journal. 45(9). 707–721. 17 indexed citations
5.
Gill, Dipender, Marie‐Joe Dib, Héléne T. Cronjé, et al.. (2024). Common pitfalls in drug target Mendelian randomization and how to avoid them. BMC Medicine. 22(1). 473–473. 14 indexed citations
6.
Gagnon, Éloi, Jérôme Bourgault, Erik Abner, et al.. (2024). Genetic assessment of efficacy and safety profiles of coagulation cascade proteins identifies Factors II and XI as actionable anticoagulant targets. European Heart Journal Open. 4(3). oeae043–oeae043.
7.
Manikpurage, Hasanga D., Jérôme Bourgault, Éloi Gagnon, et al.. (2024). Association of genetically predicted levels of circulating blood lipids with coronary artery disease incidence. Atherosclerosis. 401. 119083–119083. 1 indexed citations
8.
Guay, Simon‐Pierre, Éloi Gagnon, Martine Paquette, et al.. (2024). Pancreatitis polygenic risk score is independently associated with all‐cause acute pancreatitis risk in the UK Biobank. Journal of Gastroenterology and Hepatology. 39(12). 2639–2644. 1 indexed citations
9.
Gagnon, Éloi & Benoît J. Arsenault. (2024). Drug target Mendelian randomization supports apolipoprotein C3-lowering for lipoprotein-lipid levels reductions and cardiovascular diseases prevention. Atherosclerosis. 391. 117501–117501. 10 indexed citations
10.
Gagnon, Éloi, Jérôme Bourgault, Émilie Gobeil, Sébastien Thériault, & Benoît J. Arsenault. (2024). Impact of loss-of-function in angiopoietin-like 4 on the human phenome. Atherosclerosis. 393. 117558–117558. 10 indexed citations
11.
Gagnon, Éloi, Émilie Gobeil, Jérôme Bourgault, et al.. (2023). Genetic control of body weight by the human brain proteome. iScience. 26(4). 106376–106376. 1 indexed citations
12.
Gagnon, Éloi, Patricia L. Mitchell, Hasanga D. Manikpurage, et al.. (2023). Impact of the gut microbiota and associated metabolites on cardiometabolic traits, chronic diseases and human longevity: a Mendelian randomization study. Journal of Translational Medicine. 21(1). 60–60. 48 indexed citations
13.
Gagnon, Éloi, Hasanga D. Manikpurage, Patricia L. Mitchell, et al.. (2023). Large-scale metabolomic profiling and incident non-alcoholic fatty liver disease. iScience. 26(7). 107127–107127. 8 indexed citations
14.
15.
Gagnon, Éloi, Mara Brendgen, Frank Vitaro, et al.. (2022). From preschool language skills to writing in adolescence: Evidence of genetic continuity.. Developmental Psychology. 58(7). 1318–1330. 2 indexed citations
16.
Gagnon, Éloi, Émilie Gobeil, Jérôme Bourgault, et al.. (2022). Mendelian randomization prioritizes abdominal adiposity as an independent causal factor for liver fat accumulation and cardiometabolic diseases. SHILAP Revista de lepidopterología. 2(1). 130–130. 14 indexed citations
17.
Gobeil, Émilie, Nele Taba, Nooshin Ghodsian, et al.. (2022). Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease. Metabolites. 12(5). 440–440. 25 indexed citations
18.
Gagnon, Éloi, Michel Boivin, Bei Feng, et al.. (2022). The Intensity of Formal Child-Care Attendance Decreases the Shared Environment Contribution to School Readiness: A Twin Study. Child Psychiatry & Human Development. 55(4). 882–892. 1 indexed citations
19.
Gagnon, Éloi, Patricia L. Mitchell, & Benoît J. Arsenault. (2022). Body Fat Distribution, Fasting Insulin Levels, and Insulin Secretion: A Bidirectional Mendelian Randomization Study. The Journal of Clinical Endocrinology & Metabolism. 108(6). 1308–1317. 9 indexed citations
20.
Ghodsian, Nooshin, Éloi Gagnon, Jérôme Bourgault, et al.. (2021). Blood Levels of the SMOC1 Hepatokine Are Not Causally Linked with Type 2 Diabetes: A Bidirectional Mendelian Randomization Study. Nutrients. 13(12). 4208–4208. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniela Siváková Breakdown of academic impact, for papers by K. Radha Mani Breakdown of academic impact, for papers by Elisabeth Widén Breakdown of academic impact, for papers by Xianghong Hu Breakdown of academic impact, for papers by Kuralay Atageldiyeva Breakdown of academic impact, for papers by Àngels Ulied Breakdown of academic impact, for papers by Temeka Zore Breakdown of academic impact, for papers by Rasimcan Meral Breakdown of academic impact, for papers by Sebastian Brokat Breakdown of academic impact, for papers by Dubravka Jurišić‐Eržen
Rankless by CCL
2026